Esketamine Shows Promise as Cost-Effective Treatment for Depression in Hong Kong
A recent study highlights the cost-effectiveness of esketamine for treating treatment-resistant depression in Hong Kong compared to alternative therapies. This breakthrough could reshape mental health treatment strategies in the region.